1. Home
  2. MCHX vs XTNT Comparison

MCHX vs XTNT Comparison

Compare MCHX & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.60

Market Cap

66.3M

ML Signal

HOLD

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

N/A

Current Price

$0.52

Market Cap

68.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCHX
XTNT
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
68.9M
IPO Year
2003
2009

Fundamental Metrics

Financial Performance
Metric
MCHX
XTNT
Price
$1.60
$0.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
14.7K
100.5K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.00
EPS
N/A
0.03
Revenue
$90,291,000.00
$53,337,000.00
Revenue This Year
$5.37
N/A
Revenue Next Year
N/A
$9.30
P/E Ratio
N/A
$18.90
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$0.44
52 Week High
$2.30
$0.95

Technical Indicators

Market Signals
Indicator
MCHX
XTNT
Relative Strength Index (RSI) 40.46 49.38
Support Level $1.35 $0.44
Resistance Level $1.60 $0.67
Average True Range (ATR) 0.07 0.03
MACD -0.02 0.01
Stochastic Oscillator 24.14 42.71

Price Performance

Historical Comparison
MCHX
XTNT

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: